Amidst a surge in clinical studies delving into the transformative potential of psychedelic drugs, an intriguing paradox has emerged within the market dynamics – a notable disparity between the expanding realm of scientific exploration and the lagging valuations of companies operating in the psychedelic sector.
Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…
A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…
He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…
Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…